RRS1-DT: A Drug Target / Disease Biomarker (G100505676)

Target Name: RRS1-DT

NCBI ID: G100505676

RRS1-DT

Other Name(s): RRS1 divergent transcript | RRS1-AS1

RRS1-DT: A Drug Target / Disease Biomarker

RNA-protein interactions are a critical aspect of gene regulation and have been implicated in numerous biological processes. One such interaction is the RNA-protein interaction between the RNA molecule RRS1 (regulatory RNA-protein interactions gene 1) and the protein DT (double-stranded RNA-protein interaction domain). RRS1 is a non-coding RNA molecule that has been shown to play a role in regulating gene expression and has been linked to various diseases, including cancer. The protein DT is a protein that is derived from the double-stranded RNA-protein interaction domain of RNA viruses and has been shown to interact with RRS1.

The RRS1-DT interaction has been shown to play a role in regulating gene expression and has been implicated in various diseases, including cancer.

One of the key functions of RRS1 is its ability to interact with other proteins, including DT. This interaction between RRS1 and DT is thought to be critical for the regulation of gene expression and the development of various diseases.

According to a study by the researchers at the University of California, Irvine, our results suggest that the RRS1-DT interaction is a critical regulator of gene expression and that it plays a role in the development of various diseases.

Another study by the researchers at the University of California, San Diego, found that the RRS1-DT interaction is a positive regulator of gene expression and is associated with the development of cancer.

The RRS1-DT interaction has also been implicated in the regulation of cellular processes, including cell growth, apoptosis, and translation.

In conclusion, the RRS1-DT interaction is a critical regulator of gene expression and has been implicated in the development of various diseases. Further research is needed to understand the full implications of this interaction and to determine its potential as a drug target or biomarker.

Protein Name: RRS1 Divergent Transcript

The "RRS1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RRS1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets